[Sexual dysfunction and antihypertensive treatment: Involvement of the different therapeutic classes and what to do about the treatment of hypertension].
Dysfonction érectile et traitement antihypertenseur : impact des différentes classes thérapeutiques et conduite à tenir à l’égard du traitement.
Adrenergic alpha-1 Receptor Antagonists
/ therapeutic use
Adrenergic beta-Antagonists
/ adverse effects
Angiotensin II Type 2 Receptor Blockers
/ therapeutic use
Angiotensin-Converting Enzyme Inhibitors
/ adverse effects
Antihypertensive Agents
/ adverse effects
Calcium Channel Blockers
/ adverse effects
Cardiovascular Diseases
/ drug therapy
Diuretics
/ adverse effects
Drug Substitution
Humans
Hypertension
/ drug therapy
Male
Mineralocorticoid Receptor Antagonists
/ adverse effects
Risk Factors
Sexual Dysfunction, Physiological
/ chemically induced
Journal
Presse medicale (Paris, France : 1983)
ISSN: 2213-0276
Titre abrégé: Presse Med
Pays: France
ID NLM: 8302490
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
18
01
2019
accepted:
27
05
2019
pubmed:
16
7
2019
medline:
18
12
2019
entrez:
16
7
2019
Statut:
ppublish
Résumé
Erectile dysfunction (ED) is not routinely discussed with patients in cardiology practices whereas it may impact the ability of patients to stay on therapy. Most of the studies about ED and antihypertensive therapies have several methodological limitations. Diuretics and beta-blockers have been shown to have a deleterious effect on ED. ISRA inhibitors, calcium antagonists, vasodilator beta-blockers and alpha-blockers have been shown to have a neutral impact on ED. Angiotensin 2 inhibitors, nebivolol and alpha-blockers use has sometimes beneficial effect on ED. In case of ED due to antihypertensive treatment, drugs can be switched each other but careful attention in patients with a high cardiovascular risk is required.
Identifiants
pubmed: 31303372
pii: S0755-4982(19)30281-7
doi: 10.1016/j.lpm.2019.05.029
pii:
doi:
Substances chimiques
Adrenergic alpha-1 Receptor Antagonists
0
Adrenergic beta-Antagonists
0
Angiotensin II Type 2 Receptor Blockers
0
Angiotensin-Converting Enzyme Inhibitors
0
Antihypertensive Agents
0
Calcium Channel Blockers
0
Diuretics
0
Mineralocorticoid Receptor Antagonists
0
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
1222-1228Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.